CLDX vs MRVL · rev $37.0K vs P/E 100, rev $5.16B
Celldex Therapeutics Inc (CLDX) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
CLDX currently screens at market cap $2.35B. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the CLDX and MRVL stock pages for the full models.
Not investment advice.